cutting edge knowledge about molecular medicine from the human genome through to clinical and therapeutic strategies
Secure Genetics has evaluated research and corporate programmes and provided independent advice on genomics, epigenomics, personalized medicine and drug development initiatives for a number of companies and institutions, including a joint genome project with the University of California, Berkeley, USA and CELERA of Rockville, Maryland.
CELERA GENOMICS CORPORATION of Rockville, Maryland, USA, the private company that under J. Craig Venter sequenced the human, mouse, dog, fly and multiple microrganismal genomes.
BIOTRACES Inc of Herndon, Virginia, USA, a private biotechnology company specializing in advanced early warning detection systems for human diseases using Multi Photon Detection.
NOVARTIS Pharma AG of Basel, Switzerland and formerly of Summit, New Jersey USA, a member of the Big Pharma group of worldwide pharmaceutical companies.
AMERICAN LIFE SCIENCES PHARMACEUTICALS Inc of San Diego, California, USA, a private biotechnology company specializing in drug targets to the Alzheimers network.
HUMAN GENETIC SIGNATURES Pty Limited of Sydney, Australia, an epigenetics-based private biotechnology company specializing in methylation diagnostics of microbial and eukaryotic organisms.
FRESENIUS MEDICAL CARE AG and Co, KGaA (Asia Pacific Region), Sydney, Australia, a global Healthcare group with products and services for renal dialysis, the hospital and the medical care of patients at home.
OMICIA Inc of Emeryville, California, USA, a private biotechnology company specializing in personalized medicine.
DEUTSCHE LIFE SCIENCES GMBH of Berlin, Germany.